Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Stocks Under $50 We’re Skeptical Of

3 Stocks Under $50 We’re Skeptical Of

HAYW : 16.09 (-0.49%)
LXFR : 12.90 (-0.46%)
MED : 10.88 (+0.18%)
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

FLWS : 3.50 (+0.29%)
DBI : 4.88 (+4.72%)
MED : 10.88 (+0.18%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

MLKN : 15.76 (-1.31%)
NX : 13.85 (+1.39%)
MED : 10.88 (+0.18%)
3 Unprofitable Stocks That Fall Short

3 Unprofitable Stocks That Fall Short

OPAD : 1.8300 (-7.58%)
EL : 105.13 (+1.26%)
MED : 10.88 (+0.18%)
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Company’s Clinical Heritage and Leadership in Metabolic Health Highlighted Through Poster Presentations and Expert Contributions

MED : 10.88 (+0.18%)
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call

5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call

MED : 10.88 (+0.18%)
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges

MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges

MED : 10.88 (+0.18%)
Medifast: Q3 Earnings Snapshot

Medifast: Q3 Earnings Snapshot

MED : 10.88 (+0.18%)
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates

Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates

MED : 10.88 (+0.18%)
Medifast Announces Third Quarter 2025 Financial Results

Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. ...

MED : 10.88 (+0.18%)

Barchart Exclusives

Most “Safe” Dividend Stocks Don’t Grow Like This… But These 3 Did
Three Dividend Kings Wall Street rates “Strong Buy”, supported by strong five-year earnings growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar